Posted on 10/3/18
Eagle Pharmaceuticals Enters into Agreement with USAMRICD
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) today announced that it has entered into an agreement with the United States Army Medical Research Institute of . . .
Posted on 10/3/18
White Oak Healthcare Finance Closes Subsequent SNF Portfolio Financing for Granite Investment Group
NEW YORK--(BUSINESS WIRE)--White Oak Healthcare Finance, LLC, today announced it acted as sole lender and administrative agent on the funding of a $28 million senior credit . . .
Posted on 10/3/18
ADMA BioCenters Receives FDA Approval for Third Plasma Collection Center
RAMSEY, N.J. and MARIETTA, Ga., Oct. 03, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA), a vertically integrated commercial biopharmaceutical company that develops, manufactures and . . .
Posted on 10/3/18
Did Bristol-Myers Squibb Make a Huge Mistake With Nektar?
Earlier this year, Bristol-Myers Squibb (NYSE:BMY) made Nektar Therapeutics(NASDAQ:NKTR) a stock market darling by offering billions for rights to an experimental new cancer drug. Recently, a . . .
Posted on 10/3/18
Pfizer: Stay The Course
SummaryNew CEO coming on board.His experience lies in innovation.We expect Pfizer to become more focused after the transition especially on acquisitions.Remaining long.Looking for a portfolio of . . .
Posted on 10/3/18
Regeneron Achieves An FDA First With Immunotherapy Cancer Product
SummaryRegeneron and its partner Sanofi obtain FDA approval for Libtayo treating patients with metastatic cutaneous squamous cell carcinoma.The biotech made history in that Libtayo is the . . .
Posted on 10/2/18
Dr. Reddy's Laboratories Announces the Sale of Cloderm Cream, 0.1% Franchise to EPI Health
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. announced today that its wholly owned subsidiary Promius Pharma, LLC, has sold its rights of Cloderm® (clocortolone . . .
Posted on 10/2/18
NYC-Based Quentis Therapeutics is Named a "Fierce 15" Biotech Company of 2018
Quentis Therapeutics, Inc., a biotechnology company developing therapies that target endoplasmic reticulum (ER) stress pathways, today announced that FierceBiotech has named the company to its "Fierce15" . . .
Posted on 10/2/18
Varsity Healthcare Partners Completes Investment in Ideal Option
NEW YORK--(BUSINESS WIRE)--Varsity Healthcare Partners, a leading lower middle-market private equity firm focused on healthcare services, announced today the completion of an investment in Ideal Option, . . .
Posted on 10/2/18
FierceBiotech Names Rallybio as One of its “Fierce 15” Biotech Companies of 2018
FARMINGTON, Conn.--(BUSINESS WIRE)--Rallybio, LLC, a development stage biotechnology company, today announced that it has been named by FierceBiotech as one of 2018’s Fierce 15 biotechnology companies, . . .
Posted on 10/2/18
Johnson & Johnson Completes Divestiture Of LifeScan Business To Platinum Equity
Johnson & Johnson (NYSE:JNJ) has completed the divestiture of its LifeScan business to Platinum Equity for ~$2.1B.JNJ will discuss this transaction during its scheduled quarterly earnings . . .
Posted on 10/2/18
Pfizer Snatches FDA Approval For Rare Front-Line Lung Cancer Indication
SummaryPfizer receives FDA approval for Vizimpro which treats a rare form of lung cancer.With the latest FDA approval for Vizimpro, Pfizer now has two drugs that . . .
Posted on 10/1/18
Hitachi Chemical Advanced Therapeutics Solutions Signs Three-Year Agreement with GSK
ALLENDALE, N.J.--(BUSINESS WIRE)--Hitachi Chemical Advanced Therapeutics Solutions, LLC (HCATS) announced today that they have signed a three-year clinical manufacturing agreement with GSK, a science-led global healthcare . . .
Posted on 10/1/18
Varsity Healthcare Partners Completes Recapitalization and Growth Capital Partnership with Probo Medical
NEW YORK--(BUSINESS WIRE)--Varsity Healthcare Partners, a leading lower middle-market private equity firm focused on healthcare services, announced today the completion of a joint recapitalization transaction and . . .
Posted on 10/1/18
Dr. Reddy's Laboratories Sells Its Antibiotic Manufacturing Site and Its Related Assets in Bristol, Tennessee
Dr. Reddy’s Laboratories Ltd. today announced the closure of the sale of its antibiotic manufacturing facility and related assets in Bristol, Tennessee to Neopharma Inc
Posted on 10/1/18
Better Buy: Novavax, Inc. vs. Pfizer Inc.
On paper, there's really no contest between Novavax, Inc. (NASDAQ:NVAX) and Pfizer Inc.(NYSE:PFE). Novavax has no approved products. It doesn't have a steady source of revenue. . . .
Posted on 10/1/18
CVS/Aetna: Holding Breath Before The Blessing
SummaryCigna/Express Scripts deal gets approved by DOJ.CVS/Aetna faces regulatory concerns.Linde/Praxair is advancing the asset sale.In this post, you will find a few updates on currently followed . . .
Posted on 10/1/18
Pfizer: Where's The Stock Headed?
SummaryPfizer is heading toward an important, very long-term resistance level.We look at the technical side of Pfizer's stock history to see if there are any hints . . .
Posted on 10/1/18
Can Geron Corporation Recover From Its Breakup With Johnson & Johnson?
Plenty of biotech investors have been feeling distraught after Johnson & Johnson (NYSE:JNJ)walked away from a four-year relationship with Geron Corporation (NASDAQ:GERN) despite several nuggets of . . .
Posted on 9/30/18
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on September 25, 2018 it approved non-statutory stock options to purchase an aggregate of 122,200 shares of its . . .
Posted on 9/30/18
Taro Terminates Agreement with NovaBiotics
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE:TARO) announced today that it has terminated the license agreement with NovaBiotics for the onychomycosis drug, Novexatin®.As previously disclosed in . . .
Posted on 9/28/18
Axsome Therapeutics Announces $8.9 Million Registered Direct Offering
NEW YORK, Sept. 28, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous . . .
Posted on 9/27/18
Akari Therapeutics Enters into a Securities Purchase Agreement for up to $20 Million with Aspire Capital Fund
NEW YORK and LONDON, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics to . . .
Posted on 9/27/18
Quest Diagnostics Acquires PhenoPath
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has acquired PhenoPath
Posted on 9/27/18
pymetrics Raises $40 Million in Series B Funding Led by General Atlantic
pymetrics, an enterprise SaaS company that uses neuroscience and AI to make the recruitment process more effective, accurate, and unbiased

